Empirical Financial Services, LLC d.b.a. Empirical Wealth Management
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1510434
Seattle, WA
Position in VRTX
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$294,269
-$535,832 QoQ
Shares Held
659
-64.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 87.86039453717754.ToString("F0")%
Shared 0.ToString("F0")%
None 12.139605462822459.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Empirical Financial Services, LLC d.b.a. Empirical Wealth Management holds $8,046,747 across 13 Biotechnology names. VRTX ranks #7 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
66,223 | $1,639,680 | |
| 2 | INBX |
Inhibrx Biosciences, Inc.
|
22,584 | $1,518,322 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
5,665 | $1,070,968 | |
| 4 | PTCT |
Ptc Therapeutics, Inc.
|
13,851 | $943,667 | |
| 5 | ORKA |
Oruka Therapeutics, Inc.
|
18,229 | $894,131 | |
| 6 | EXEL |
Exelixis, Inc.
|
9,450 | $405,310 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
659 | $294,269 | |
| 8 | ACAD |
Acadia Pharmaceuticals Inc
|
12,923 | $287,665 |
All Filings in VRTX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $294,269 | 659 | Shares | Other | 2026-05-04 | |
| 2025-12-31 | $830,101 | 1,831 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $655,996 | 1,675 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $913,550 | 2,052 | Shares | Other | 2025-07-21 | |
| 2025-03-31 | $890,614 | 1,837 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $278,265 | 691 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $392,527 | 844 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $397,005 | 847 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $522,930 | 1,251 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $426,420 | 1,048 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $340,785 | 980 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $352,261 | 1,001 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $424,084 | 1,346 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $388,697 | 1,346 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $401,012 | 1,385 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $501,022 | 1,778 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $544,122 | 2,085 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $856,440 | 3,900 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,083,261 | 5,972 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $794,623 | 3,941 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $518,314 | 2,412 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||